CAPR
Caprock Mining Corp.
$3.93
+0.08 (+2.08%) ↑
As of Aug 10, 2026, 9:34 AM EDT· Delayed 15 min
$228M
Market Cap
Who holds this
No tracked investor holdings disclosed for this company yet.
Get Alerts for Caprock Mining Corp. (CAPR)
Get notified when a tracked investor or company insider files a buy or sell for CAPR. Alerts cover US SEC filings (Form 4 and 13F) that GoldSignal ingests.
Insider buying
No recent insider transactions on file.
Gold beta
CAPR Gold Beta
Gold beta is not computable for CAPR (insufficient history, liquidity, or gold relationship). Sample peers below show the beta range; this stock is not plotted.
Caprock Mining Corp.
CAPRCSE
Gold beta measures how much this stock tends to move for every 1% move in the price of gold.
Gold Beta
N/A
Not computable
R-squared
N/A
Model fit unavailable
Reliability-Adjusted Beta
N/A
R²-weighted beta
Observation Window
252-DAY
Daily returns
How to read
β > 1.1
amplifies gold moves
β 0.9-1.1
tracks gold
β 0-0.9
dampens gold moves
β < 0
moves inversely
Gold beta is not computable for CAPR because the measured benchmark relationship fell below the publication floor.
R-squared is unavailable because this regression is not publishable.
Methodology: OLS regression of CAPR returns vs. GLD returns over 252 trading days. Source: Polygon.io price data. Updated daily.
Company Details
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
HeadquartersSan Diego, CA
Key Stats
At a Glance
Ownership from tracked investor filings and public statements. Insider buying from SEC filings (Form 4).